Evista (raloxifene) might help prevent breast cancer in postmenopausal women

March 1999

New research suggests that Evista (raloxifene) might help prevent breast cancer in postmenopausal women.

Women taking Evista for osteoporosis seem to have a 60% lower risk of developing breast cancer.

This is similar to the benefit that's seen with tamoxifen.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

The United States Pharmacopeia (USP) is now setting standards for some herbal products
Heart Failure earlier and more aggressive treatment for systolic heart failure
Heart Failure more heart failure patients on amiodarone (Cordarone)
Diabetes low-dose ASA for MOST adults with diabetes
Interactions more drugs that can interact with grapefruit juice
Pediatrics Giving amoxicillin just ONCE a day may be effective for treating Strep throat in children
Women's Health Evista (raloxifene) might help prevent breast cancer in postmenopausal women
Women's Health Rumors are running rampant over the Internet about tampons and about aspartame (NutraSweet)
Colon Cancer calcium supplements might reduce the risk of colon cancer
Metabolife 356
Antithrombotics You'll see more patients monitoring their own warfarin therapy
HPB has approved Activase (alteplase, t-PA) for ischemic stroke
new drug for intermittent claudication
Lots of pharmacies are now springing up on the Internet
Practice Ident-A-Drug Reference